pd 142893 has been researched along with a 192621 in 1 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (a 192621) | Trials (a 192621) | Recent Studies (post-2010) (a 192621) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 84 | 0 | 8 |
| Protein | Taxonomy | pd 142893 (IC50) | a 192621 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.0051 | |
| Endothelin-1 receptor | Homo sapiens (human) | 9.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asham, E; Boulos, PB; Burnstock, G; Fredericks, S; Loizidou, M; Miller, K; Shankar, A; Taylor, I | 1 |
1 other study(ies) available for pd 142893 and a 192621
| Article | Year |
|---|---|
Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism.
Topics: Adult; Aged; Aged, 80 and over; Animals; Colon; Colorectal Neoplasms; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Oligopeptides; Peptides, Cyclic; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B | 2001 |